BAXALTA VENTURES
Baxalta Ventures invests globally in healthcare companies developing novel products and therapies consistent with Baxalta’s commitment to strive for excellence on behalf of patients, caregivers and healthcare providers. The Baxalta Ventures team brings unique expertise in products and therapies across the pharmaceuticals, medical devices, and biotechnology sectors. As part of Baxalta, they have access to additional expertise in product research, development, manufacturing, and commercializa... tion to their work with entrepreneurs. Baxalta Ventures believe that establishing strong relationships with entrepreneurs, other venture capital investors, and industry experts is critical for the long-term success of their portfolio companies. They aim to accelerate and enhance commercialization activities in portfolio companies by creating strategic alliances with other venture capital funds and by leveraging Baxalta’s expertise in clinical development, production, and marketing of therapeutic solutions. Baxalta Ventures is managed by an experienced leadership team with extensive expertise in venture capital, scientific innovation, and operational leadership in the healthcare industry. Their initial investments are generally up to $5 million and may increase throughout the life of the company.
BAXALTA VENTURES
Social Links:
Industry:
Finance Financial Services Venture Capital
Founded:
2015-01-01
Status:
Active
Contact:
44 (0) 20 3655 2400
Technology used in webpage:
Amazon Route 53 Pound Sterling ATT
Similar Organizations
Action Potential Venture Capital
Action Potential Venture Capital is a strategic venture capital fund that invests in bioelectronic medicine and technology companies.
Fremont Ventures
Fremont Ventures is a private investment firm specialized in network infrastructure, core technologies, and life science technologies.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-06-21 | Syntimmune | Baxalta Ventures investment in Series B - Syntimmune | 50 M USD |
| 2016-11-17 | Syntimmune | Baxalta Ventures investment in Series A - Syntimmune | 8 M USD |
| 2016-03-29 | Gadeta | Baxalta Ventures investment in Series A - Gadeta | 7 M EUR |
| 2016-03-22 | Syntimmune | Baxalta Ventures investment in Series A - Syntimmune | 10 M USD |
| 2015-12-03 | True North Therapeutics | Baxalta Ventures investment in Series C - True North Therapeutics | 40 M USD |
| 2014-10-24 | Syntimmune | Baxalta Ventures investment in Series A - Syntimmune | 8 M USD |
More informations about "Baxalta Ventures" on Search Engine
Baxalta - Wikipedia
Baxalta (Bax from the name of its former parent company; alta a Latin adjective meaning 'high' or 'profound' ) is a biopharmaceutical company founded on 1 July 2015 after its parent company, Baxter International, spun off biopharmaceutical division. The company began its operation with a revenue of $6 billion, and is now a subsidiary of Takeda Pharmaceutical Company.See details»
Shire to Combine with Baxalta, Creating the Global …
Jan 11, 2016 Combination creates leading global biotechnology company projected to deliver double-digit top-line growth with over $20 billion in annual revenues by 2020. No. …See details»
Baxalta: A Deep Valued Product Pipeline And Attractive …
Baxalta Ventures: This is the newly formed venture capital arm of Baxalta aimed at providing seed capital to promising healthcare firms. I expect significant promising investments in...See details»
How Baxter’s Biosciences Spin-off into Baxalta Improved Its …
Mar 19, 2016 On July 1, 2015, Baxter International (BAX) separated its Biosciences division into a new entity named Baxalta (BXLT). The company did this in an effort to divest its …See details»
UPDATED: Shire goes public with a $30B bid to acquire Baxalta, …
Aug 4, 2015 After getting stiff-armed by the newly independent management at Baxter's ($BAX) biotech spinoff Baxalta, Shire ($SHPG) is going public with its offer to acquire the …See details»
Baxter and Baxalta Highlight Business Strategies at …
May 18, 2015 Consistent with its commitment to innovation, Baxalta has implemented a new patient-centric R&D model, expects to launch 20 new products, which will contribute …See details»
Shire Completes Combination With Baxalta Creating the …
Jun 3, 2016 Shire plc (LSE: SHP, NASDAQ: SHPG) today completed its previously announced combination with Baxalta Incorporated (NYSE: BXLT ), creating the leading …See details»
Baxter Ventures, Mayo Clinic and Velocity …
Jun 1, 2015 Following the spin-off of Baxter BioScience as Baxalta Incorporated, anticipated to take place by mid-2015, the Vitesse relationship will be managed by the planned venture arm, Baxalta Ventures, for the …See details»
UPDATED: Baxalta signs off on a $1.6B checkpoint pipeline deal …
Jan 4, 2016 Clinical Data. Even as word of a looming Shire ($SHPG) buyout continued to heat up over the weekend, Baxalta ($BXLT) was readying an announcement that it has …See details»
Shire, Baxalta Complete $32B Merger - genengnews.com
Jun 3, 2016 Baxalta is the former Baxter BioScience global biopharmaceutical business spun off in July of 2015 by Baxter International, with a focus on developing new …See details»
Baxalta Ventures - Contacts, Employees, Board Members, …
Baxalta Ventures is a biotech investment fund focused on novel therapeutics, medical technologies, and more.See details»
Global Head of Business Development at Rallybio - The Org
In 2015, they joined Baxalta as Partner of Baxalta Ventures. In 2016, they were Head of Business Development at Velocity Pharmaceutical Development and also began working …See details»
Baxalta Ventures - Investor, United States - SWFI
Baxalta Ventures: Investor in United States, North America. Baxalta Ventures is a Investor located in United States, North America. Request Profile Update; Download DataSee details»
The state of corporate venture capital in Canada - Deloitte US
Although Canada’s CVC sector is gaining momentum, there’s still considerable room for more participation, especially in comparison with the activity seen in the United States. …See details»
HOME | Neatly Ever After
At Neatly Ever After, we are committed to creating custom organizational systems that target the challenging areas of your home. We leave you with organizational solutions that last …See details»
Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical …
Jun 1, 2015 DEERFIELD, Ill., ROCHESTER, Minn. and SOUTH SAN FRANCISCO, Calif., June 1, 2015 /PRNewswire/ -- Baxter Ventures, the venture arm of Baxter International …See details»
Old Town Warrenton - About Us
Organization. Building a strong foundation for a sustainable effort, including cultivating partnerships, community involvement and relationships with investors. Executives. Joelle …See details»
Baxalta Ventures - Crunchbase
Baxalta Ventures is a biotech investment fund focused on novel therapeutics, medical technologies, and more.See details»
Fauquier High School | Fauquier Music Organization | United States
Fauquier High School Music 705 Waterloo Rd. Warrenton, VA 20186 Fauquier Music Organization PO Box 255 Warrenton, VA 20188 Email: [email protected]See details»
KuCoin Ventures Announces Strategic Investments in ELFi
49 minutes ago ABOUT KUCOIN VENTURES. KuCoin Ventures aims to invest in the most disruptive crypto and blockchain projects of the 3.0 era. As a community …See details»